&nbsp;

MOSAIC_Placemat.pdf

Jan 2022

Document

mosaicPlacemat.jpg

Feb 2022

Regimen

HYPERCVAD+PEG

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

New Drug Funding Program

Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2022

Regimen

MFOLFOX6+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jan 2024

Regimen

MATRIX

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Drugs Used:

riTUXimab (Unfunded),

methotrexate,

cytarabine,

thiotepa (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2024

Hepatitis B Virus Screening and Management for Patients Receiving Systemic Treatment

Cancer facts

More support for commercial tobacco prevention, cessation and protection efforts is needed among First Nations communities in Ontario

Sep 2022

Guidelines and Advice

Hepatitis B Virus Screening and Management for Patients Receiving Systemic Treatment

Status: Current

Sep 2022

Cancer facts

Moins de ressources matérielles associées à une incidence plus élevée du cancer

Oct 2022

Document

HCP_Should-my-patients-start-on-a-biosimilar.pdf

Nov 2022

Document